BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miller JL, Tyrrell BE, Zitzmann N. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus. Adv Exp Med Biol 2018;1062:277-301. [PMID: 29845540 DOI: 10.1007/978-981-10-8727-1_20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Perera N, Brun J, Alonzi DS, Tyrrell BE, Miller JL, Zitzmann N. Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells. Antiviral Research 2022. [DOI: 10.1016/j.antiviral.2022.105269] [Reference Citation Analysis]
2 Wang Z, Yang L. Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies, benefits, and challenges. J Med Virol 2021. [PMID: 34897729 DOI: 10.1002/jmv.27517] [Reference Citation Analysis]
3 Warfield KL, Schaaf KR, DeWald LE, Spurgers KB, Wang W, Stavale E, Mendenhall M, Shilts MH, Stockwell TB, Barnard DL, Ramstedt U, Das SR. Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B. Sci Rep 2019;9:7484. [PMID: 31097731 DOI: 10.1038/s41598-019-43030-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
4 Miller JL, Hill ML, Brun J, Pountain A, Sayce AC, Zitzmann N. Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus. Antiviral Res 2019;170:104551. [PMID: 31306674 DOI: 10.1016/j.antiviral.2019.104551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Lim SP. Dengue drug discovery: Progress, challenges and outlook. Antiviral Res 2019;163:156-78. [PMID: 30597183 DOI: 10.1016/j.antiviral.2018.12.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
6 Wilder-Smith A, Ooi EE, Horstick O, Wills B. Dengue. Lancet. 2019;393:350-363. [PMID: 30696575 DOI: 10.1016/s0140-6736(18)32560-1] [Cited by in Crossref: 179] [Cited by in F6Publishing: 110] [Article Influence: 59.7] [Reference Citation Analysis]
7 Sayce AC, Martinez FO, Tyrrell BE, Perera N, Hill ML, Dwek RA, Miller JL, Zitzmann N. Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response. Immunology 2021. [PMID: 34287854 DOI: 10.1111/imm.13393] [Reference Citation Analysis]
8 Clarke EC, Nofchissey RA, Ye C, Bradfute SB. The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication. Glycobiology 2021;31:378-84. [PMID: 32985653 DOI: 10.1093/glycob/cwaa091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
9 Dhiman M, Sharma L, Dadhich A, Dhawan P, Sharma MM. Traditional Knowledge to Contemporary Medication in the Treatment of Infectious Disease Dengue: A Review. Front Pharmacol 2022;13:750494. [PMID: 35359838 DOI: 10.3389/fphar.2022.750494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Breitinger U, Farag NS, Ali NKM, Ahmed M, El-Azizi MA, Breitinger HG. Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels. J Gen Virol 2021;102. [PMID: 33709903 DOI: 10.1099/jgv.0.001571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Evans DeWald L, Starr C, Butters T, Treston A, Warfield KL. Iminosugars: A host-targeted approach to combat Flaviviridae infections. Antiviral Res 2020;184:104881. [PMID: 32768411 DOI: 10.1016/j.antiviral.2020.104881] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Franco EJ, Pires de Mello CP, Brown AN. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus. Viruses 2021;13:771. [PMID: 33925551 DOI: 10.3390/v13050771] [Reference Citation Analysis]
13 Misumi I, Li Z, Sun L, Das A, Shiota T, Cullen J, Zhang Q, Whitmire JK, Lemon SM. Iminosugar glucosidase inhibitors reduce hepatic inflammation in HAV-infected Ifnar1-/- mice. J Virol 2021:JVI. [PMID: 33692213 DOI: 10.1128/JVI.00058-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Fusade-Boyer M, Dupré G, Bessière P, Khiar S, Quentin-Froignant C, Beck C, Lecollinet S, Rameix-Welti MA, Eléouët JF, Tangy F, Lajoie B, Bertagnoli S, Vidalain PO, Gallardo F, Volmer R. Evaluation of the Antiviral Activity of Sephin1 Treatment and Its Consequences on eIF2α Phosphorylation in Response to Viral Infections. Front Immunol 2019;10:134. [PMID: 30809223 DOI: 10.3389/fimmu.2019.00134] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
15 Puet A, Domínguez G, Cañada FJ, Pérez-Castells J. Amino Acid-Based Synthesis and Glycosidase Inhibition of Cyclopropane-Containing Iminosugars. ACS Omega 2020;5:31821-30. [PMID: 33344836 DOI: 10.1021/acsomega.0c04589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wolfsgruber A, Thonhofer M, Weber P, Nasseri SA, Fischer R, Schalli M, Stütz AE, Withers SG, Wrodnigg TM. N-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-Glucocerebrosidase. Molecules 2020;25:E4618. [PMID: 33050585 DOI: 10.3390/molecules25204618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]